Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 3
2005 8
2006 7
2007 5
2008 6
2009 7
2010 5
2011 2
2012 3
2013 6
2014 5
2015 3
2016 7
2017 15
2018 13
2019 11
2020 5
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Results by year

Filters applied: . Clear all
Page 1
Endotoxin Activity Reflects an Increase in Body Temperature in Cirrhotic Patients With Ascites Undergoing Cell-free and Concentrated Ascites Reinfusion Therapy.
Namisaki T, Tsuji Y, Kitade M, Yorioka N, Fujinaga Y, Sawada Y, Nishimura N, Kitagawa K, Inoue T, Takaya H, Kaji K, Kawaratani H, Moriya K, Akahane T, Mitoro A, Yoshiji H. Namisaki T, et al. Among authors: kitade m. In Vivo. 2022 May-Jun;36(3):1477-1484. doi: 10.21873/invivo.12854. In Vivo. 2022. PMID: 35478114 Free PMC article.
Novel oral plasminogen activator inhibitor‑1 inhibitor TM5275 attenuates hepatic fibrosis under metabolic syndrome via suppression of activated hepatic stellate cells in rats.
Noguchi R, Kaji K, Namisaki T, Moriya K, Kawaratani H, Kitade M, Takaya H, Aihara Y, Douhara A, Asada K, Nishimura N, Miyata T, Yoshiji H. Noguchi R, et al. Among authors: kitade m. Mol Med Rep. 2020 Oct;22(4):2948-2956. doi: 10.3892/mmr.2020.11360. Epub 2020 Jul 28. Mol Med Rep. 2020. PMID: 32945412 Free PMC article.
Bile Acid Sequestrant, Sevelamer Ameliorates Hepatic Fibrosis with Reduced Overload of Endogenous Lipopolysaccharide in Experimental Nonalcoholic Steatohepatitis.
Tsuji Y, Kaji K, Kitade M, Kaya D, Kitagawa K, Ozutsumi T, Fujinaga Y, Takaya H, Kawaratani H, Namisaki T, Moriya K, Akahane T, Yoshiji H. Tsuji Y, et al. Among authors: kitade m. Microorganisms. 2020 Jun 19;8(6):925. doi: 10.3390/microorganisms8060925. Microorganisms. 2020. PMID: 32575352 Free PMC article.
Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis.
Furukawa M, Moriya K, Nakayama J, Inoue T, Momoda R, Kawaratani H, Namisaki T, Sato S, Douhara A, Kaji K, Kitade M, Shimozato N, Sawada Y, Saikawa S, Takaya H, Kitagawa K, Akahane T, Mitoro A, Yamao J, Tanaka Y, Yoshiji H. Furukawa M, et al. Among authors: kitade m. Hepatol Res. 2020 Jul;50(7):840-852. doi: 10.1111/hepr.13509. Epub 2020 Jun 10. Hepatol Res. 2020. PMID: 32346970
Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis.
Ozutsumi T, Namisaki T, Shimozato N, Kaji K, Tsuji Y, Kaya D, Fujinaga Y, Furukawa M, Nakanishi K, Sato S, Sawada Y, Saikawa S, Kitagawa K, Takaya H, Kawaratani H, Kitade M, Moriya K, Noguchi R, Akahane T, Mitoro A, Yoshiji H. Ozutsumi T, et al. Among authors: kitade m. Int J Mol Sci. 2020 Mar 21;21(6):2164. doi: 10.3390/ijms21062164. Int J Mol Sci. 2020. PMID: 32245205 Free PMC article.
Acylcarnitine: Useful biomarker for early diagnosis of hepatocellular carcinoma in non-steatohepatitis patients.
Takaya H, Namisaki T, Kitade M, Shimozato N, Kaji K, Tsuji Y, Nakanishi K, Noguchi R, Fujinaga Y, Sawada Y, Saikawa S, Sato S, Kawaratani H, Moriya K, Akahane T, Yoshiji H. Takaya H, et al. Among authors: kitade m. World J Gastrointest Oncol. 2019 Oct 15;11(10):887-897. doi: 10.4251/wjgo.v11.i10.887. World J Gastrointest Oncol. 2019. PMID: 31662827 Free PMC article.
VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma.
Takaya H, Namisaki T, Kitade M, Kaji K, Nakanishi K, Tsuji Y, Shimozato N, Moriya K, Seki K, Sawada Y, Saikawa S, Sato S, Kawaratani H, Akahane T, Noguchi R, Matsumoto M, Yoshiji H. Takaya H, et al. Among authors: kitade m. BMC Gastroenterol. 2019 Oct 21;19(1):167. doi: 10.1186/s12876-019-1082-1. BMC Gastroenterol. 2019. PMID: 31638892 Free PMC article.
Combined effect of a farnesoid X receptor agonist and dipeptidyl peptidase-4 inhibitor on hepatic fibrosis.
Shimozato N, Namisaki T, Kaji K, Kitade M, Okura Y, Sato S, Moriya K, Seki K, Kawaratani H, Takaya H, Sawada Y, Saikawa S, Nakanishi K, Furukawa M, Fujinaga Y, Kubo T, Asada K, Kitagawa K, Tsuji Y, Kaya D, Ozutsumi T, Akahane T, Mitoro A, Yoshiji H. Shimozato N, et al. Among authors: kitade m. Hepatol Res. 2019 Oct;49(10):1147-1161. doi: 10.1111/hepr.13385. Epub 2019 Jul 15. Hepatol Res. 2019. PMID: 31177586
99 results